These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 26067692)
1. Unilateral Perivascular Infiltrates in Lupus Retinopathy. Warren CC; Gendy MG; Kim JE JAMA Ophthalmol; 2015 Jun; 133(6):e145367. PubMed ID: 26067692 [No Abstract] [Full Text] [Related]
2. [Interdisciplinary consensus to management of lupus nephritis in Germany]. de Groot K Z Rheumatol; 2007 Dec; 66(8):724, 726. PubMed ID: 17965864 [TBL] [Abstract][Full Text] [Related]
3. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide. Burchardi C; Schlöndorff D Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452 [No Abstract] [Full Text] [Related]
4. Treatment of lupus nephritis--a work in progress. Falk RJ N Engl J Med; 2000 Oct; 343(16):1182-3. PubMed ID: 11036127 [No Abstract] [Full Text] [Related]
5. The treatment of lupus nephritis. D'Cruz DP; Hughes GR BMJ; 2005 Feb; 330(7488):377-8. PubMed ID: 15718519 [No Abstract] [Full Text] [Related]
6. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Karassa FB; Isenberg DA N Engl J Med; 2001 Feb; 344(5):382-3. PubMed ID: 11195799 [No Abstract] [Full Text] [Related]
7. Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis. Ann Intern Med; 2015 Jan; 162(1):I24. PubMed ID: 25383607 [No Abstract] [Full Text] [Related]
9. Myasthenia gravis associated with lupus nephritis. Lee H; Chen W; Su K; Chou C; Tsai C Lupus; 2008 Sep; 17(9):860-1. PubMed ID: 18755870 [No Abstract] [Full Text] [Related]
10. Successful treatment of combined proliferative and membranous lupus nephritis using a full corticosteroid-free regimen. Tedeschi B; Arnaud L; Hie M; Mathian A; Amoura Z Ann Rheum Dis; 2014 Feb; 73(2):474-5. PubMed ID: 24001887 [No Abstract] [Full Text] [Related]
11. Posterior retinal vasculitis associated with multiple sclerosis. Mackenzie PJ; Chang TS; Hay D Retina; 2002 Feb; 22(1):133-4. PubMed ID: 11884901 [No Abstract] [Full Text] [Related]
12. Bilateral retinal vasculopathy in a patient with dyskeratosis congenita. Teixeira LF; Shields CL; Marr B; Horgan N; Shields JA Arch Ophthalmol; 2008 Jan; 126(1):134-5. PubMed ID: 18195234 [No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Glicklich D; Acharya A Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620 [TBL] [Abstract][Full Text] [Related]
14. Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange. Samson M; Audia S; Leguy V; Berthier S; Janikashvili N; Martin L; Bonnotte B; Lorcerie B Intern Med J; 2012 Jan; 42(1):95-8. PubMed ID: 22276560 [TBL] [Abstract][Full Text] [Related]
15. Induction and maintenance therapy in proliferative lupus nephritis. Ponticelli C; Glassock RJ; Moroni G J Nephrol; 2010; 23(1):9-16. PubMed ID: 20091481 [TBL] [Abstract][Full Text] [Related]
16. Autoimmune hepatitis: current knowledge. Vajro P; Paolella G Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):284-6. PubMed ID: 22521122 [TBL] [Abstract][Full Text] [Related]
17. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558 [TBL] [Abstract][Full Text] [Related]
18. [Childhood onset systemic lupus erythematosus: how does it must be treated in 2010?]. Bader-Meunier B Arch Pediatr; 2010 Jun; 17(6):632-3. PubMed ID: 20654815 [No Abstract] [Full Text] [Related]